Healthcare · NYSE/NASDAQ: HUM
HUMANA INC
Healthcare Plans
Market Cap $45.65B
Verdict: Average
Quality Scores
Multi-Bagger
42/100
Compounder Quality
60/100
Management Credibility
55/100
Governance
82/100
Cash Flow Quality
52/100
AI Summary
Humana Inc. has evolved from a concentrated healthcare provider into a massive integrated care entity, with revenues scaling from approx $13B in 2016 to nearly $130B by 2025. Despite this 10x top-line expansion, the bottom-line performance has significantly decoupled from revenue growth in recent years, specifically since 2020. The company faces a difficult environment characterized by rising medical loss ratios (MLR) and regulatory pressure on Medicare Advantage. While assets have nearly doubled over the decade, net income in 2024-2025 has compressed back to levels seen years prior when the…
Top Opportunities
- Consistent double-digit revenue growth
- Dominant position in Medicare Advantage market
- Diversified services via CenterWell segment
Top Risks
- Severe operating margin compression
- Recent collapse in net income consistency
- Critical regulatory risk from Medicare Star Rating changes
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.